Metformin repositioning in rheumatoid arthritis.
CONCLUSIONS: These results suggest that metformin might improve the pathogenesis of RA, including joint inflammation and destruction. Thus, metformin might be utilised as a potential therapeutic agent in the treatment of RA.
PMID: 32828146 [PubMed - as supplied by publisher]
Source: Clinical and Experimental Rheumatology - Category: Rheumatology Tags: Clin Exp Rheumatol Source Type: research
More News: Arthritis | Autoimmune Disease | Cancer & Oncology | Diabetes | Endocrinology | Fortamet | Genetics | Metformin | Rheumatoid Arthritis | Rheumatology